scout
|Videos|April 18, 2022

Venetoclax in Combination with Daratumumab for Multiple Myeloma Treatment

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. A look at clinical trial efficacy data on daratumumab plus bortezomib and venetoclax for multiple myeloma treatment.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME